Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy

Severe side effects often restrict clinical application of the widely used chemotherapeutic drug doxorubicin. In order to decrease required substance concentrations, new concepts for successful combination therapy are needed. Since doxorubicin causes DNA damage, combination with compounds that modul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Pfitzer, Lisa, Moser, Christina, Gegenfurtner, Florian, Arner, Anja, Foerster, Florian, Atzberger, Carina, Zisis, Themistoklis, Kubisch-Dohmen, Rebekka, Busse, Johanna, Smith, Rebecca, Timinszky, Gyula, Kalinina, Olga V., Müller, Rolf, Wagner, Ernst, Vollmar, Angelika M., Zahler, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447524/
https://ncbi.nlm.nih.gov/pubmed/30944311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1546-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados